...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Exempt Distributions - Dec 9, 2022 & Jan 13, 2023

,,acchhhhh,,DMcC's friends probably get these PPs,,,if he has any left!!,,,,notice the expiry date,,2028,,,,5 years down the road!!,,and they will probably expire worthless!!!,,lmao ,,,,,,,you bet, the retailer never received a 5 year spread on their warrants,,,I assume the exercise price is a few pennies as well,,with a hold of a few months,,no boy,,,,RVX likes to bank for themselves and shaft the retailer!!,,the sooner this company gets out of my pocket and off my account records the better for my overall health!!,,Pitiful company from a$$ whole to appetite!

Share
New Message
Please login to post a reply